Mergers and Acquisitions - DingTong Technology plans to acquire 70% equity of Blue Ocean Vision for 126 million yuan, making it a subsidiary after the transaction [1] - Dongfang Zhizao intends to purchase 70% equity of Nantong Saifu Machinery Equipment for 27.4887 million yuan using its own funds [3] - Bangji Technology has terminated its plan to acquire 100% equity of Shandong Beixi Agricultural and Animal Husbandry Co., Ltd. and 80% equity of Paistong Livestock Technology Consulting (Shanghai) Co., Ltd. [2] Shareholding Changes - Sobao Protein's shareholder Jinan Fosun and its concerted parties plan to reduce their holdings by up to 3%, totaling a maximum of 574.38 million shares [4] - Hetai Electromechanical's shareholder Hangzhou Hetai Jinghua plans to reduce its holdings by up to 2.98%, equating to a maximum of 195.98 million shares [5] - Hongtong Gas's shareholder Tian Hui intends to reduce his holdings by up to 3%, which amounts to a maximum of 848.64 million shares [6] - Zhonggu Logistics's shareholder Ningbo Guyang Investment Management plans to reduce its holdings by up to 3% [7] Risk Matters - ST Chang Pharmaceutical's stock has experienced a cumulative decline of 34.98% over two consecutive trading days, indicating a risk of delisting due to abnormal fluctuations and ongoing investigations by the regulatory authority [8]

Company Announcements - *ST Zhengping has completed the stock suspension review and will resume trading on November 12, confirming normal production and operation without significant changes [1] - Upwind New Materials is in the product development stage for its embodied intelligent robot business, which has not yet achieved mass production or revenue generation [2] - Shannon Chip Innovation's fourth largest shareholder, Shenzhen Xinlianpu, has pledged 1.27 million shares for financing purposes [3] - Qing Shui Yuan's phosphorus trichloride products are primarily used in the production of water treatment agents [4] - Midea Group announced a cash dividend plan of 5 yuan per 10 shares, totaling 3.448 billion yuan, with the record date on November 17 [4] - Huiyuan Communication is planning a change of control, leading to a stock suspension starting November 12 [5] - Shen Gong Co. has clarified that some research reports on its performance forecasts represent only analysts' personal views [6] - World is developing diamond micro-drills for PCB processing, which are still in the R&D phase [6] - Haike New Source has signed an agreement with Kunlun New Materials for the purchase of 596,200 tons of electrolyte solvent [7] - Tongxing Technology plans to invest 3.2 billion yuan in a project to produce 100,000 tons of sodium battery cathode materials and 6 GWh battery cells [8] Investments & Contracts - Zhongjin Irradiation is investing 200 million yuan to build an electronic accelerator intelligent manufacturing project [10] - Hongri Da is collaborating with Te Du Technology and Hongke Tongchuang to establish a joint venture for semiconductor packaging [10] Shareholding Changes - Jian Kai Technology's controlling shareholder Xuanzhao plans to transfer 3% of its shares through a pricing inquiry [12] - Yue Wannianqing's shareholder Hehe Investment intends to reduce its stake by up to 3% [14] Financing & Capital Increase - Weiteng Electric plans to raise up to 300 million yuan through a private placement for various manufacturing projects [22] Other Developments - Zhifei Biological has received approval for clinical trials of a vaccine for adolescents and adults [23] - Shanghai Kaibao has obtained approval for clinical trials of a drug for acute ischemic stroke [24]

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-031 宁波索宝蛋白科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东的基本情况 截至本公告披露日，宁波索宝蛋白科技股份有限公司(以下简称"公司") 的股东济南财金复星惟实股权投资基金合伙企业(有限合伙)(以下简称"济南复 星")持有公司股份 13,473,046 股，占公司总股本的 7.037%，其一致行动人上 海复星创富投资管理股份有限公司－宁波梅山保税港区复星惟盈股权投资基金 合伙企业(有限合伙)（以下简称"宁波复星"）持有公司股份 13,473,046 股，占 公司总股本的 7.037%。上述股份的来源均为公司 IPO 前取得的股份，已于 2024 年 12 月 16 日上市流通。济南复星与宁波复星为一致行动人关系，合计持有公司 股份 26,946,092 股，占公司总股本的 14.074%。 减持计划的主要内容 济南复星、宁波复星处于自身经营发展需要，拟通过集中竞价或大宗交易方 式减持公 ...

Core Viewpoint - The company, Sobo Protein (603231.SH), announced that Jinan Fosun and Ningbo Fosun plan to reduce their holdings in the company by a total of up to 5.7438 million shares, which represents no more than 3% of the company's total share capital [1] Summary by Category - **Shareholding Reduction** - Jinan Fosun and Ningbo Fosun intend to reduce their stakes in Sobo Protein through centralized bidding or block trading [1] - The total number of shares to be reduced is up to 5.7438 million [1] - This reduction accounts for a maximum of 3% of the company's total share capital [1]

Group 1 - The core point of the news is that Sobor Protein announced a share reduction plan by its major shareholders, which may impact the stock price and investor sentiment [1] - As of the announcement date, Jinan Caijin Fuxing Weishi Equity Investment Fund holds approximately 13.47 million shares, accounting for 7.037% of the total share capital, while its concerted action partner, Shanghai Fuxing Chuangfu Investment Management, holds an equal amount [1] - The combined shareholding of Jinan Fuxing and Ningbo Fuxing amounts to approximately 26.95 million shares, representing 14.074% of the total share capital [1] Group 2 - The planned share reduction will involve a maximum of approximately 574,000 shares, which is not more than 3% of the total share capital, with 191,000 shares to be sold through centralized bidding and 383,000 shares through block trading [1] - The reduction period will commence 15 trading days after the announcement and will last for three months, with the selling price determined by market conditions [1] - As of the latest report, Sobor Protein's revenue composition shows that the agricultural and sideline food processing industry accounts for 99.61% of its revenue, with a market capitalization of 4.2 billion yuan [2]

Core Viewpoint - The company, Sobor Protein (603231.SH), announced that Jinan Fosun and Ningbo Fosun plan to reduce their holdings in the company by a total of up to 5.7438 million shares, which represents no more than 3% of the company's total share capital [1] Summary by Categories - **Share Reduction Plan** - Jinan Fosun and Ningbo Fosun intend to reduce their stakes in Sobor Protein through centralized bidding or block trading [1] - The total number of shares to be reduced is up to 5.7438 million [1] - This reduction accounts for a maximum of 3% of the company's total share capital [1]

Core Viewpoint - The company, Suobao Protein (603231.SH), announced that its shareholders, Jinan Fosun and Ningbo Fosun, plan to reduce their holdings in the company by a total of up to 5.7438 million shares, which represents no more than 3% of the company's total share capital [1] Summary by Category Shareholding Reduction Plan - The shareholders intend to reduce their holdings through centralized bidding or block trading methods, with a maximum of 1.9146 million shares (up to 1% of total share capital) to be sold via centralized bidding [1] - Additionally, up to 3.8292 million shares (up to 2% of total share capital) will be sold through block trading [1] - The reduction period will commence 15 trading days after the announcement of this reduction plan, specifically starting from December 3, 2025, and will last for three months [1] - The selling price during the reduction will be determined based on market prices [1]

人民财讯11月11日电，索宝蛋白（603231）11月11日公告，股东济南财金复星惟实股权投资基金合伙企 业(有限合伙)(简称"济南复星")和其一致行动人上海复星创富投资管理股份有限公司-宁波梅山保税港区 复星惟盈股权投资基金合伙企业(有限合伙)(简称"宁波复星")拟通过集中竞价或大宗交易方式，减持公 司股份合计不超过574.38万股，即不超过公司总股本的3%。济南复星与宁波复星为一致行动人关系， 合计持有公司股份2694.61万股，占公司总股本的14.07%。 ...

Core Points - The shareholders of Sobor Protein, Jinan Caijin Fuxing Weishi Equity Investment Fund Partnership (Limited Partnership) and its concerted party Ningbo Meishan Bonded Port Area Fuxing Weiying Equity Investment Fund Partnership (Limited Partnership), hold a total of 26.9461 million shares, accounting for 14.074% of the company's total equity [1] - Jinan Fuxing and Ningbo Fuxing plan to reduce their holdings by no more than 5.7438 million shares, which is up to 3% of the total equity [1] - The reduction will occur through centralized bidding or block trading, with a period set from December 3, 2025, to March 2, 2026, and the selling price will be determined by market conditions [1] Summary by Category Shareholding Structure - Jinan Fuxing and Ningbo Fuxing collectively hold 26.9461 million shares, representing 14.074% of Sobor Protein's total equity [1] Reduction Plan - The planned reduction involves a maximum of 5.7438 million shares, equating to 3% of the total equity [1] - The reduction will be executed via centralized bidding (up to 1.9146 million shares) and block trading (up to 3.8292 million shares) [1] Timeline and Pricing - The reduction period is scheduled from December 3, 2025, to March 2, 2026 [1] - The selling price will be based on market prices at the time of the transaction [1]

格隆汇11月11日丨索宝蛋白(603231.SH)公布，济南复星、宁波复星处于自身经营发展需要，拟通过集 中竞价或大宗交易方式减持公司股份合计不超过574.38万股，即不超过公司总股本的3%。其中，拟通 过集中竞价交易方式减持不超过191.46万股，即不超过公司总股本的1%；拟通过大宗交易方式减持不 超过382.92万股，即不超过公司总股本的2%。减持期间自本减持计划公告披露之日起15个交易日后 （即2025年12月3日后）的3个月内，减持价格按市场价格确定。 ...